Elon is hell-bent on eliminating or cutting the deficit. GLP-1s may make a meaningful dent in medical costs but the demand for medical treatments is unlimited. I agree the odds are stacked against them but we should all endeavor to find a solution now that the will is there.
GLP-1s and Medical Cost Control in Deficit Reduction
By
–
Leave a Reply